US Business

The company has seen sales hit by alternative compounded versions of its blockbuster weight-loss and diabetes drugs, particularly in the U.S.

The healthcare-equipment company posted a rise in net profit and revenue for its fiscal second quarter but widened its adjusted earnings per share range on increased tariff uncertainty.

The group doesn’t expect to be affected by U.S. tariffs on U.K. imports, since the vast majority of the equipment it sells to the U.S. is produced there.

The carmaker reiterated its forecasts for the year, but said actual performance might deviate from these projections if tariffs remain in place for longer than expected.

The combined group will have a global presence in over 40 countries, serving around 50 million monthly active users, the companies said.

The health-technology group posted lower first-quarter sales and earnings as its CEO said it was particularly hit by trade tariffs imposed between both countries.

The Chinese battery giant has filed a preliminary prospectus with the Hong Kong exchange for a secondary listing, as it seeks to tap enthusiasm surrounding the EV market.

The company reported a better-than-feared performance, and backed its full-year guidance despite what it called a tough backdrop.

In an interview, Chief Executive Dale Henderson spoke of how Pilbara Minerals, or PLS, is prioritizing cost savings after ramping up the expansion of its Pilgangoora lithium mine in remote northwest Australia.

Prices plunged after OPEC and its allies agreed to increase output again, despite weak prices and an uncertain demand outlook.